Big Pharma’s AI race extends across drug discovery, development, and clinical trials—but AstraZeneca has distinguished itself by deploying AI clinical trials technology at an unprecedented public health scale. While competitors optimise internal R&D pipelines, AstraZeneca’s AI is already embedded in national healthcare systems, screening hundreds of thousands of patients and demonstrating what happens when AI
The post AstraZeneca leads big pharma’s AI clinical trials revolution with real-world patient impact appeared first on AI News. Read More
